Company: CI
Filing Date: 2025-09-02
Form Type: 424B5
Source: 0001140361-25-033574
Chunk: 11

Company: Cigna Group
Filing Date: 2025-09-02
Form: 424B5
Chunk 11
---
 Shareholders’ Net Income            |                   |     |                                         $2,855 |      |     |                        $3,434 |      |     |   $5,164 |
| Net Income                          |                   |     |                                         $3,041 |      |     |                        $3,778 |      |     |   $5,372 |
| Shareholders’ Net Income Per Share  |                   |     |                                                |      |     |                               |      |     |          |
| Basic                               |                   |     |                                         $10.63 |      |     |                        $12.25 |      |     |   $17.57 |
| Diluted                             |                   |     |                                         $10.55 |      |     |                        $12.12 |      |     |   $17.39 |
| Common Dividends Declared Per Share |                   |     |                                          $3.02 |      |     |                         $5.60 |      |     |    $4.92 |
| Cash and Investments                |                   |     |                                        $20,804 |      |     |                       $23,343 |      |     |  $26,732 |
| Total Assets                        |                   |     |                                       $151,651 |      |     |                      $155,881 |      |     | $152,761 |
| Long-Term Debt                      |                   |     |                                        $26,480 |      |     |                       $28,937 |      |     |  $28,155 |
| Total Liabilities                   |                   |     |                                       $111,221 |      |     |                      $114,638 |      |     | $106,410 |
| Shareholders’ Equity                |                   |     |                                        $40,214 |      |     |                       $41,033 |      |     |  $46,223 |

S-5

#### TABLE OF CONTENTS

### USE OF PROCEEDS
Our net proceeds from this offering are estimated to be approximately $    , after deducting underwriting discounts and estimated offering expenses.

We intend to use the net proceeds from this offering (i) to repay $2.0 billion of loans outstanding under the Term Loan Facility, the proceeds of which were used to fund a strategic investment in another company, and (ii) the remainder for general corporate purposes, which may include investments and repayment of indebtedness. Pending such use, the net proceeds may be invested